Merck Animal Health Announces $100 Million Investment in its DeSoto, Kansas, Manufacturing Operations
DESOTO, Kan., June 29, 2020– Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, today announced an investment of $100 million in facility expansion and enhancement efforts in its U.S. manufacturing site in DeSoto, Kansas. Investments to the site include…Read More
FDA-approval granted to Huvepharma® for estrus suppression feed additive CycleGuard® 500 (melengestrol acetate Type A liquid medicated article)
PEACHTREE CITY, GA (June 24, 2020) — Huvepharma® has received FDA-approval for CycleGuard® 500, a melengestrol acetate feed additive used for suppression of estrus in heifers. Available as a Type A liquid medicated article, CycleGuard® 500 is a bio-equivalent product to MGA® and HeiferMaX®,…Read More
Portland, Maine [June 19, 2020] – Rotavirus disease can intensify within a herd when infected calves shed the pathogen into the environment, exposing and infecting other calves. A recent study by Dr. Andy Skidmore*, in collaboration with Dr. Jan Gawthrop, evaluated if First Defense…Read More
Vaxxinova will market one-of-a-kind vaccine WILLMAR, MN – Vaxxinova US (formerly Epitopix) announces Vaxxon® SRP® Klebsiella as the new name for KLEBVax SRP, a mastitis vaccine recently marketed by Huvepharma USA. Vaxxinova indicates Vaxxon SRP Klebsiella is identical to KLEBVax and remains the only…Read More
Our Mission Statement: To provide readers with the most up-to-date information on the beef industry in concise, easy-to-read articles designed to increase overall awareness among the feedlot community.